Price T Rowe Associates Inc 4 D Molecular Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

  • $812 Billion
  • Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 26,528 shares of FDMT stock, worth $92,582. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,528
Previous 26,546 0.07%
Holding current value
$92,582
Previous $148,000 41.89%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$3.23 - $6.6 $58 - $118
-18 Reduced 0.07%
26,528 $86,000
Q4 2024

Feb 14, 2025
SELL
$5.3 - $10.41 $21,141 - $41,525
-3,989 Reduced 13.06%
26,546 $148,000
Q3 2024

Nov 14, 2024
BUY
$10.81 - $27.22 $5,307 - $13,365
491 Added 1.63%
30,535 $331,000
Q2 2024

Aug 14, 2024
BUY
$20.93 - $30.01 $127,505 - $182,820
6,092 Added 25.43%
30,044 $631,000
Q1 2024

May 15, 2024
BUY
$17.03 - $35.87 $23,092 - $48,639
1,356 Added 6.0%
23,952 $764,000
Q4 2023

Feb 14, 2024
BUY
$9.76 - $21.25 $10,794 - $23,502
1,106 Added 5.15%
22,596 $458,000
Q3 2023

Nov 14, 2023
BUY
$12.64 - $19.76 $32,484 - $50,783
2,570 Added 13.58%
21,490 $274,000
Q2 2023

Aug 14, 2023
BUY
$15.16 - $23.26 $8,171 - $12,537
539 Added 2.93%
18,920 $342,000
Q1 2023

May 15, 2023
BUY
$15.45 - $23.19 $15,480 - $23,236
1,002 Added 5.77%
18,381 $316,000
Q4 2022

Feb 14, 2023
SELL
$6.85 - $25.46 $4,993 - $18,560
-729 Reduced 4.03%
17,379 $386,000
Q3 2022

Nov 14, 2022
BUY
$6.96 - $11.48 $16,133 - $26,610
2,318 Added 14.68%
18,108 $146,000
Q2 2022

Aug 15, 2022
BUY
$5.68 - $15.99 $25,077 - $70,595
4,415 Added 38.81%
15,790 $110,000
Q1 2022

May 16, 2022
BUY
$13.16 - $22.64 $9,212 - $15,848
700 Added 6.56%
11,375 $172,000
Q4 2021

Feb 14, 2022
BUY
$19.56 - $32.94 $208,803 - $351,634
10,675 New
10,675 $234,000
Q2 2021

Aug 16, 2021
SELL
$22.2 - $42.29 $6.21 Million - $11.8 Million
-279,746 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$35.94 - $52.67 $2.3 Million - $3.37 Million
-63,932 Reduced 18.6%
279,746 $12.1 Million
Q4 2020

Feb 16, 2021
BUY
$38.43 - $47.36 $13.2 Million - $16.3 Million
343,678 New
343,678 $14.2 Million

Others Institutions Holding FDMT

# of Institutions
128
Shares Held
43.5M
Call Options Held
25.8K
Put Options Held
33.4K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $113M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email